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Optimization of stress response through
the nuclear receptor-mediated cortisol
signalling network
Alexey Kolodkin1,*, Nilgun Sahin2,*, Anna Phillips3, Steve R. Hood4, Frank J. Bruggeman2,5,6,
Hans V. Westerhoff2,7,8 & Nick Plant3
It is an accepted paradigm that extended stress predisposes an individual to pathophysiology.
However, the biological adaptations to minimize this risk are poorly understood. Using a
computational model based upon realistic kinetic parameters we are able to reproduce the
interaction of the stress hormone cortisol with its two nuclear receptors, the high-afﬁnity
glucocorticoid receptor and the low-afﬁnity pregnane X-receptor. We demonstrate that
regulatory signals between these two nuclear receptors are necessary to optimize the body’s
response to stress episodes, attenuating both the magnitude and duration of the biological
response. In addition, we predict that the activation of pregnane X-receptor by multiple, low-
afﬁnity endobiotic ligands is necessary for the signiﬁcant pregnane X-receptor-mediated
transcriptional response observed following stress episodes. This integration allows
responses mediated through both the high and low-afﬁnity nuclear receptors, which we
predict is an important strategy to minimize the risk of disease from chronic stress.
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T
here is a requirement for robustness within biological
systems, deﬁned as the ability of a system to undertake its
core function despite external challenges1. Product
inhibition, feed-forward and feed-back inhibition and
stimulation, as well as repression and induction regulatory
loops allow biological systems to approach both robustness and
adaptability2. Biological systems are routinely exposed to external
challenge, such as the stress response where each challenge causes
a transient spike in blood cortisol, activating catecholamine
production in the brain and glucose mobilization in the liver,
forming the classical ﬁght or ﬂight response3. It is clear that
prolonged or repeated stress is associated with the development
of pathophysiology4–6; for example, high stress police work
is associated positively with the development of metabolic
syndrome7,8. As such, it is both an important biological
question, and challenging modelling scenario, to understand
how these metabolic networks function efﬁciently, balancing both
the pharmacodynamic (physiological effect of the challenge on
the biological system) and pharmacokinetic (metabolic response
to the challenge, leading to a return to homoeostasis) responses to
stress: This ensures an efﬁcient ﬁght or ﬂight response, while
minimizing the overstimulation associated with increased
morbidity.
Many genes responsible for the body’s responses to chemical
and environmental challenge are regulated by members of
the nuclear receptor superfamily9. These ligand-activated
transcription factors may be divided into receptors with high-
afﬁnity ligands (KdBnM; for example, the glucocorticoid
receptor (GR)), and those with low-afﬁnity ligands (KdBmM;
for example, the pregnane X-receptor (PXR))9,10.
Regulatory signals have been identiﬁed between nuclear
receptors, although the impact of these on target gene expression
is at present equivocal. Examples of such regulation include
the positive regulation of PXR by GR11; the positive regulation
of PXR by peroxisome proliferator activated receptor a12,
and the negative autoregulation of GR, progesterone receptor,
androgen receptor and PXR on their own expression13–15.
Indeed, the nuclear receptor network in its entirety holds
multiple interlinked complex regulatory mechanisms16,17, the
quantitative importance of which is only just becoming clear.
Using a systems biology approach we reproduce a portion of
this regulatory network in silico, based on both literature and on
de novo-generated data, and demonstrate that the model can
reproduce the known interactions between glucocorticoids, their
cognate receptors and target gene sets. We demonstrate the utility
of feed-forward and feed-back regulatory signals in optimizing
the response to a stress challenge. Importantly, we demonstrate
that the regulatory network only functions as a direct result of the
promiscuity of the PXR ligand proﬁle, with integration from
multiple, low-afﬁnity endogenous chemicals being obligate for
activation of PXR by the nanomolar concentrations of cortisol
released during a stress response. Finally, as multiple stress
exposures are a more likely scenario in the real world, we examine
how the system responds to repeated stimuli of differing
frequency. We demonstrate that the network is robust towards
low frequency perturbations, shows adaptation at moderate stress
frequencies, but transitions to an altered steady state at high
frequency stimulation, which we predict is predisposing towards
stress-induced pathologies.
Results
Model generation and validation. We generated an in silico
model of the regulatory signal network known to regulate
body responses to glucocorticoids in the human liver, allowing
examination of both pharmacodynamic and pharmacokinetic
responses to stress. Figure 1a represents a cartoon of the basic
network structure, while Supplementary Fig. S1 provides the
complete model in Systems Biology Graphical Notation format
and Supplementary Tables S1–S4 the model parameters, balance
equations, conserved moieties and initial conditions used to
populate the model, respectively. Within this model, cortisol
(ligand ‘L’) may interact with two nuclear receptors; the high-
afﬁnity GR and the low-afﬁnity PXR. Activation of GR by ligand,
forming the GR-ligand complex (GRL), has three effects on the
network: First, a feed-back regulatory signal causes transcrip-
tional repression of GR13; second, a feed-forward regulatory
signal increases PXR expression, again at the transcriptional
level11; third, GRL upregulates the transcription of a target gene
set, including the classic marker gene tyrosine aminotransferase
(TAT18), which we use to represent the pharmacodynamic
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Figure 1 | Regulatory signal network under study and model validation.
(a) A single ligand (L) acts as an agonist for both PXR and GR, forming
an activated complex (hashed outline). Activated GR controls both the
expression of target genes involved in the pharmacodynamic effect cortisol
(for example, the expression of TAT) of its ligand L (often cortisol) and PXR
expression. Activated PXR controls the expression of target gene involved in
the pharmacokinetic response (for example, CYP3A4), which acts to
remove the stimulating ligand (L). (b) Primary human hepatocytes were
exposed to vehicle or (0.1–50000nM) cortisol as indicated for 48 h, RNA
extracted and transcript levels of PXR, GR, CYP3A4 and TAT quantiﬁed by
TaqMan quantitative PCR. Average transcript levels (±s.e.m.) from
triplicate cultures are indicated by open symbols, and the concentration-
response curve shown by the full line was ﬁtted to these data. Transcript
levels of PXR, GR, CYP3A4 and TAT following 48h exposure to indicated
concentrations of cortisol were also simulated by the model, and are
presented as closed symbols. (c) Primary human hepatocytes were as
above and total protein extracted. CYP3A4 protein and activity levels were
measured, with the average (±s.e.m.) from triplicate cultures indicated by
open symbols, with concentration-response curve again ﬁtted to the
experimental data. Simulations of CYP3A4 protein and activity levels are
presented as closed symbols.
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response. Activation of PXR by ligand (forming PXRL) has a
single action; stimulation of a second target gene set, including
the marker gene CYP3A4 (ref. 19). The reduction in concentration
of ligand L by an enhanced activity of CYP3A4 is incorporated
into the model, allowing us to simulate the dynamic response to
ligand challenge, and making CYP3A4 a surrogate marker for the
pharmacokinetic response. It should be noted that while
heterologous overexpression experiments have shown that GR
activation can have an impact on CYP3A4 reporter gene
expression20 other in vitro experiments clearly demonstrate that
any interaction must be indirect as there is no consensus GR
response element within the CYP3A4 regulatory region21, and GR
ChIP-Seq experiments fail to demonstrate a direct interaction22,23.
The model is deﬁned by series of balance and rate equations.
Where available, parameters were taken from the literature
(Supplementary Table S1), with the remaining parameters ﬁtted
to the known biological behaviour of the system, while
maintaining these parameters within biologically realistic bounds
(for example, average gene transcription rate). Using these
speciﬁcations, the model corresponds to the most realistic
possible considering the current state of knowledge.
The model was validated by reproducing the response of
primary human hepatocytes exposed to the glucocorticoid cortisol.
Cortisol is a high-afﬁnity GR ligand (Kd¼ 10 nM, ref. 24), and a
low-afﬁnity PXR ligand (Kd¼ 10mM, ref. 24). As can be seen from
Fig. 1b, the model replicates the dose-dependent modulation of
GR, PXR, CYP3A4 and TAT steady-state mRNA levels observed
in primary human hepatocytes exposed to cortisol; moreover, the
model was able to qualitatively replicate the increases in CYP3A4
protein and activity levels observed in primary human hepatocytes
(Fig. 1c). Furthermore, the model replicates the effect of the
artiﬁcial glucocorticoid dexamethasone on primary human
hepatocytes (Supplementary Fig. S2).
All the predicted changes were half complete at cortisol
concentrations of B10 nM, equivalent to the Kd for its binding
to GR. This is readily understood for TAT, GR and PXR as they
are all impacted by the level of GRL. CYP3A4 mRNA and protein
concentrations were also half regulated at 10 nM cortisol, which is
potentially counterintuitive as CYP3A4 expression is regulated by
PXRL, and yet the Kd between cortisol and PXR is B1,000-fold
higher than this. As such, the need for further examination of the
network is clear.
These results demonstrate that the generated in silico network
was sufﬁciently parameterized to allow meaningful interrogation
of the biological scenario. It should be noted that although these
data prove the model competent to describe the variations in the
indicated species following cortisol challenge, they do not
conclusively prove the ﬁdelity of the model for other properties
and perturbations.
Impact of GR-mediated feed-back regulatory signal on net-
work. GRL invokes both a negative feed-back loop on GR
expression and a positive feed-forward regulation on PXR tran-
scription. To examine the importance of these regulatory inter-
actions, we simulated the dynamics of the network following a
sustained increase of cortisol levels. We then determined the
importance of the two regulatory interactions by disabling either
the negative feed-back loop (a network variant we shall refer to
as ‘GRstubborn’), or the positive feed-forward regulation (the
‘PXRstubborn’ variant).
In the wild-type network, a decrease in both the transcript and
protein levels of GR were simulated in response to a sustained
intracellular level of 10 nM cortisol, conﬁrming the operation of
the GR-mediated autoregulatory feed-back loop (Fig. 2a). In
addition, the increases in both PXR transcript and protein levels
were semi-transient in nature, with the reduction of PXR
expression by GRL via the feed-forward signal providing the
mechanistic rationale. Simulation of the same exposure on the GR
stubborn network predicted no alteration in transcript or protein
levels for GR (both GRþGRL) and a persistent elevation in PXR
due to the sustained higher GRL levels (Fig. 2a). Hence, the GR-
mediated negative feed-back loop can be seen to impact upon
levels of GR (directly) and PXR (indirectly).
The GR negative feed-back loop also impacts on the expression
of GR and PXR target genes. The negative feed-back loop acts to
attenuate expression of the classical GR target gene TAT (Fig. 2b),
with the GR stubborn variant resulting in a predicted temporal
persistence of TAT expression. This negative feed-back loop also
produces a modest decrease in the long-term expression of the
PXR target gene CYP3A4 (Fig. 2b).
Impact of GR-mediated feed-forward regulatory signal. We
next examined the role of the GR-mediated feed-forward signal,
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Figure 2 | GR-mediated negative feed-back on GR expression. Transcript and protein levels for (a) GR and PXR, and (b) CYP3A4 and TAT, were simulated
over 3,000min following addition (in silico) of cortisol to a constant level of 10 nM. Solid lines represent levels simulated for the complete single-ligand
model, whereas dashed lines represent levels GR stubborn and PXR stubborn scenarios as indicated.
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whereby GRL stimulates PXR gene expression. The PXR stubborn
variant predicted no alteration in transcript or protein levels for
PXR, or TAT and GR in response to 10 nM intracellular cortisol,
the latter being understandable as their regulation is controlled
upstream of this regulatory loop within the network (Fig. 2a). For
the PXR stubborn variant, the increase in CYP3A4 levels fol-
lowing 10 nM intracellular cortisol was less than simulated in the
complete model, but the change in Area Under the concentra-
tion-time Curve (AUC) was modest (B15%: Fig. 2b).
The molecular rationale behind this apparent lack of control
becomes clear if the relative afﬁnities of cortisol towards PXR and
GR are considered: The Kd of cortisol for PXR is B1,000-fold
higher than the Kd for GR. A biologically realistic maximal
intracellular concentration for cortisol is 10 nM, as used in this
simulation, and results in 50% occupancy of GR (KdE10 nM),
but only 0.1% occupancy for PXR (KdE10mM). Under the
simulated exposure paradigm, total PXR protein level is predicted
to increase by 17 nM due to the GRL-mediated feed-forward
regulatory signal. However, this results in an increase of PXRL of
o0.02 nM, producing a very small impact on PXR target gene
expression. Given that these conditions are biologically realistic
with respect to receptor and ligand concentrations, plus the
afﬁnity of cortisol for both GR and PXR, we are left with a
paradox; why does a feed-forward regulatory signal exist that
appears poorly functional under normal biological conditions?
To answer this apparent paradox, we further considered the
basic biology of PXR. Although originally described as a pro-
miscuous nuclear receptor with many endogenous and xenobiotic
ligands26–28, PXR has largely become thought of as a
xenosensor29,30. Recent work has refocused on the role of PXR
in endogenous processes15,31,32, and we would suggest that the
known feed-forward regulation of PXR expression by
endosensing steroid hormone receptors such as the GR, ER and
PPAR11,14 would be supportive of such a role. At any given time
the intracellular milieu will contain a number of low-afﬁnity
endogenous PXR ligands, and we must, therefore, consider not
only the role of individual endobiotic ligands, but also their
collective effect. Each of these ligands (L1yLn) individually is
present in the cell at a low concentration (nM), and coupled with
low afﬁnities (KdEmM) occupancy of PXR by any one ligand
(PXRL1...PXRLn) would be negligible. However, if the levels of
these endogenous ligands are integrated, then it should be
possible to achieve a total ligand pool that will result in a
signiﬁcant level of PXR occupancy. This would result in a higher
level of activated PXR under baseline conditions, and hence PXR
target genes such as CYP3A4. Importantly, the GR-mediated
feed-forward regulatory signal means that cortisol challenge now
has an unexpected effect; increased PXR leads to not only an
increase in PXRL (for example, PXR activated by cortisol) but
also PXRL2..PXRLn (for example, PXR activated by all other
endogenous ligands, hereafter referred to as ligand pool L2).
To examine this scenario we introduced a second ligand pool
(L2), representing the integration of all endogenous ligands for
PXR present within the cell. This pool was set to a concentration
of 100 nM, with a Kd¼ 10mM, which we believe is not
inconsistent with a biologically realistic value. The model
parameters, balance equations, conserved moieties and initial
conditions used to populate this model are presented in
Supplementary Tables S5–S8, respectively. Following addition of
the second ligand pool, the impact of cortisol challenge to a
sustained intracellular level of 10 nM on the network was
simulated for the wild-type, GR stubborn and PXR stubborn
networks (Fig. 3). As predicted, the presence of the L2 ligand pool
had little impact upon the dynamic response of PXR, GR or TAT.
For CYP3A4, however, two notable effects were predicted: First,
the transcript and protein levels were signiﬁcantly higher under
the steady-state baseline before cortisol addition (1,628 nM versus
111 nM for L1þ L2 and L1 alone, respectively). Second, the GR-
mediated feed-forward regulatory signal is now fully functional,
being responsible for B80% of the increase in CYP3A4 AUC
observed upon cortisol challenge. This strong dependence on the
feed-forward regulation is understandable as added cortisol has a
dual effect on CYP3A4 expression; the ﬁrst is rapid and due to
binding of L to pre-existing PXR. The second is slower and is due
to binding of L and L2 to PXR that is produced de novo through
the action of the GRL-mediated feed-forward regulatory signal.
Together, these effects increase the total activated PXR pool
(PXRLþ PXRL2) by over 10-fold compared with PXRL alone.
An intriguing extension of this prediction is that L2 ligand pool
size actually drives target gene induction, with larger L2 pools
producing signiﬁcantly more activated PXR (PXRLþ PXRL2)
due to the GR-mediated feed-forward regulatory signal.
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Supplementary Fig. S3 demonstrates that as L2 pool size
increases, so does the predicted basal expression of CYP3A4,
while the degree to which it can be further induced decreases.
This inverse correlation is supported by literature data, where fold
induction of metabolic enzymes in primary human hepatocytes
was observed to be inversely correlated with their basal expression
level for a range of inducers33.
Dynamics of the network following multiple stress episodes.
All previous simulations were undertaken using a ﬁxed intracel-
lular concentration of 10 nM cortisol, consistent with our
experimental model system. However, a more clinically relevant
scenario involves an acute spike of cortisol released into the
bloodstream following a stress episode. Moreover, in modern
society many individuals are exposed to a number of stress events
sequentially. We thus used the complete model to ask how the
gene regulatory network responds to repeat blood cortisol spikes,
equivalent to sequential stress episodes.
Three different frequencies of stress episodes were examined;
1 per week, 1 per day or 1 per hour, corresponding to ‘low-’,
‘medium-’ and ‘high-’ stress scenarios. Simulated protein levels
for each of these scenarios are presented in Fig. 4, with transcript
level simulations as Supplementary Data (Supplementary Fig. S4).
In the low-stress scenario all species were predicted to return to
baseline following each stress episode, making each stress
response independent. In contrast, the medium stress scenario
produces new mean expression levels for all species, with protein
levels oscillating around this new mean. For TAT, this mean
approximates the maximal level of TAT expression seen during
the low-stress scenario; in contrast, GR, PXR and CYP3A4 var-
iances are greater. These data are consistent with an adaptive
response, where the network has moved to a new steady state that
acts to limit the magnitude of the pharmacodynamic response, as
measured by TAT expression. It is of particular note that while
there is a substantial increase in blood cortisol between low and
moderate frequency scenarios (AUC¼ ﬁvefold increase and
Cmax¼ 2.9-fold increase), the increase in TAT levels is sig-
niﬁcantly less (AUC¼ 3.6-fold increase and Cmax¼ 1.6-fold
increase): This is consistent with a successful adaptation to
medium frequency stress. However, high stress conditions predict
large variances in all species in the model, suggesting a failure to
adapt. We suggest that the resultant permanent increase in
pharmacodynamic response, as measured by TAT expression,
represents overstimulation and a predisposition to increased
morbidity. It is also important to note that alteration in non-GR
target genes may be important in modulating morbidity. For
example, expression levels of the PXR target gene CYP3A4, are
predicted to increase dramatically in the high stress scenario
(AUC¼ 12.8-fold increase and Cmax¼ 9.2-fold increase), and as
CYP3A4 is responsible for the metabolism of a large number of
endogenous steroids19,30 this may impact upon the homoeostasis
of these steroids, also contributing to increased morbidity.
Despite this failure to adapt, the network can still minimize the
impact of high stress to some degree; a dramatic increase in blood
cortisol levels compared with the low-stress scenario is observed
(AUC¼ 89-fold increase and Cmax¼ 31.4-fold increase), but
the increase in TAT expression levels is signiﬁcantly muted
(AUC¼ 7-fold increase and Cmax¼ 2.4-fold increase).
Finally, we simulated the TAT and blood cortisol levels under
conditions of moderate frequency stress episodes, for both the
wild-type network and a variant where both GR-mediated
regulatory signals had been disabled (GR/PXR Stubborn
variant). The regulatory signals have no impact on the blood
cortisol level, but the level of TAT was signiﬁcantly impacted by
the GR/PXR stubborn variant, with 1.3-fold increases in both
AUC and Cmax compared with the wild-type network simulated
(Fig. 4). From this we can conclude that the main action of the
regulatory signals is to minimize the pharmacodynamic response
to repeated stress episodes, effectively de-sensitizing the body to
chronic stress.
Adaptation to chronic stress is re-enforced through low-stress
periods. One of the design features of the network simulated
herein is the ability to adapt to moderate levels of stress. Given
that workdays are, generally, more stressful than non-workdays,
we asked if a weekend break was beneﬁcial for our ability to
respond to moderate stress, and if an extended vacation was even
better.
Figure 5 shows the simulated protein levels of all species
following once per day stress events under three scenarios: con-
tinuous stress every day for 21 days; a weekend scenario with
5 days of stress, followed by 2 days with no stress, for 21 days; a
vacation scenario with 5 days of stress, followed by 9 days with no
stress, and then 5 days of stress. Transcript levels are presented in
Supplementary Fig. S5. In the weekend scenario, predicted levels
mirrored the 21-day constant stress scenario for the ﬁrst 5 days,
as expected. Protein levels for all species were predicted to return
towards baseline during the low-stress weekend, but did not fully
recover. TAT protein levels were predicted to reach 82% of their
baseline value, while PXR and CYP3A4 reached 75% and 77%,
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Figure 4 | Response of the gene regulatory network to repeat stress
episodes. (a) Protein levels for GR, PXR, CYP3A4 and TAT, as well as free
blood cortisol, were simulated over 21 days following addition of repeat
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respectively. In contrast, GR protein levels were predicted to only
reach 45% of their baseline value. The net effect of this is a
‘biological memory’ within the network to the ﬁrst stress episode.
However, the impact of this biological memory is, perhaps
surprisingly, minimal, with the response to stress on day 8 being
only negligibly smaller than on day 1. However, during a 9-day
vacation there appears to a signiﬁcant memory effect, with the
response to stress on the ﬁrst day back from vacation being
signiﬁcantly less that the response seen on day 1.
Discussion
The glucocorticoid class of steroid hormones undertake a large
number of functions central to normophysiology; additionally,
they respond to external stress challenge, producing the ‘ﬁght or
ﬂight’ response34. Much recent interest has focussed on the
association between chronic stress and predisposition towards
disease states, including a number of complex pathologies
such as metabolic syndrome4,35, hippocampal vulnerability6,
depression36 and drug–induced liver injury37. Using a systems
modelling approach we have examined the regulatory signal
network that underlies the cortisol-driven stress response under
both normophysiology and following stress episodes.
The signal regulatory network is centred around the interaction
of the stress hormone cortisol with two nuclear receptors; a high-
afﬁnity ligand with GR, and low-afﬁnity ligand with PXR
(B1,000-fold difference in Kd). Glucocorticoids have previously
been shown to activate feed-back and feed-forward regulatory
signals on GR and PXR expression, respectively11,13, which we
demonstrate are important in regulating the network response as
a whole. As such, we describe an important emergent feature of
the network; the buffering of TAT levels relative to cortisol level
following repeat stress episodes, consistent with an adaptation to
minimize the physiological response and reducthe risk of disease
progression. Such data is consistent with the clinical observation
of Kirschbaum et al.38, who examined the response of healthy
men to daily stress events. In these individuals they observed that
subsequent stress events causing a reduced response. Even under
the high stress scenario, a large degree of buffering occurs;
however, given the available human data we would suggest that
this is insufﬁcient to prevent a marked increase in morbidity. For
example, the chronic stress associated with combat scenarios has
been associated with generalized disease phenotypes, such as
post-traumatic stress disorder39.
In general, workdays are more stressful compared with
weekends, yet our simulations predict that there is negligible
difference between a stress response on day 1 of the medium
stress scenario, and on day 8, following a weekend of no stress. In
contrast, following a short vacation, we predict a muted response
compared with the day 1 (naive) response. A potential
explanation for this is the differential kinetics of cortisol and
the GR: cortisol is degraded relatively quickly as CYP3A4 levels
are high at the start of the vacation and remain so until the
cortisol level drops sufﬁciently for the GRL-mediated feed-
forward regulatory signal to become inactive and for PXR protein
to then degrade. In contrast, GR levels are inﬂuenced by the level
of GRL, which is auto-inhibitory on GR transcription. As such,
the increase in GR expression level following cessation of the
stress episodes is predicted to lag behind the decrease in cortisol
levels as it is dependent upon both the initial loss of cortisol to
terminate the GRL-mediated auto-inhibitory signal, and the need
to transcribe and translate GR de novo. Whilst the impact of this
differential kinetics cannot be seen following a short weekend
break, over a 9-day vacation there is sufﬁcient time for a positive
memory to emerge, effectively de-sensitizing the network to
further stress episodes.
It should be noted that the model presented represents only a
single portion of the entire biological system. We cannot exclude
the possibility of compensatory changes to other proteins outside
the modelled network. It would be expected that, for example, an
increase in CYP3A4 levels would increase metabolism of its many
endogenous substrates, initiating feed-forward regulatory signals
to increase steroid synthesis and return to homoeostasis. Indeed,
one potential reason for the evolution of such a regulatory signal
network may be energy conservation, whereby a tight regulation
of degradative processes is necessary to prevent futile energy
expenditure through unnecessary anabolic processes.
In addition, we provide a solution to the paradox that
endogenous chemicals are often ligands for both low-afﬁnity
and high-afﬁnity receptors. As intracellular levels of these steroid
hormones are generally several orders of magnitude lower than
their Kd for low-afﬁnity receptors, this suggests the level of PXRL
will always remain low, and effectively biologically silent. Building
on the knowledge that PXR is a promiscuous receptor with
multiple endogenous ligands26–28 we demonstrate that
integration of these individual ligands (PXRL1yPXRLn) results
in a signiﬁcant increase of PXRL, increasing transcriptional
activation of PXR target genes at baseline. Furthermore, through
the use of the feed-forward regulatory loop, whereby GRL
increases PXR protein levels, a single ligand (for example,
cortisol) can have a biologically important impact on activated
PXR, impacting upon both its own occupation of PXR (PXRL)
and other PXR ligands (PXRL2yLn; PXRL2).
In summary, we present a systems modelling approach to
understand the design principles underlying the biological
response to stress. We demonstrate that this network is able to
regulate both the magnitude and duration of the physiological
response to a stress episode, which we believe is an important
design feature to protect against increased morbidity due to
chronic overstimulation. In addition, we demonstrate that this
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Figure 5 | A low-stress vacation is required to allow adaptation to a
stressful week. Protein levels for GR, PXR, CYP3A4 and TAT, as well as free
blood cortisol, were simulated over 21 days following addition of repeat
spikes of cortisol, such that each spike doubled the free blood cortisol
concentration. Cortisol spikes were applied 1 per day for either continuous
throughout the period (grey line), with a weekend break (black line) or a
9-day vacation (dashed line).
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system is robust against repeated stress episodes, producing only
small variations in the physiological response for large increases
of blood free-cortisol. Finally, we suggest that the differential
kinetics of species within the network mean that a sustained
vacation leads to a ‘biological memory’, lessening the response to
subsequent stress episodes.
Methods
Primary cell culture. Primary human hepatocytes were a kind gift of
GlaxoSmithKline, and were seeded at 2.4 105 cells cm 2 in 25 cm2 ﬂasks and
allowed to attach overnight. Cells were dosed daily with vehicle, cortisol or dex-
amethasone (Sigma-Aldrich, Poole, UK) at the indicated concentrations. Following
48 h of exposure, total RNA and protein was isolated from quadruplicate samples.
Total RNA was isolated using the RNeasy Mini kit (Qiagen, Crawley, UK) and
quantiﬁed using a Nanodrop Agilent 2100 Bioanalyser, while total protein was
extracted in RIPA buffer (1PBS, 1% Nonidet P40, 0.5% sodium deoxycholate,
0.1% SDS, protease inhibitor cocktail).
Transcript level measurement. Primers and TAMRA/FAM dual-labelled probe
speciﬁc for PXR, GR, CYP3A4 and 18S were designed using the Primer Express
software (Applied Biosystems, Warrington, UK) and were purchased from Euroﬁns
(Wolverhampton, UK). Total RNA was treated with RNase-free DNase (Promega,
Southampton, UK) to remove genomic contamination. Reverse transcription was
primed with random hexamers and carried out by Superscript II (Invitrogen) as
per the manufacturer’s instructions. To ensure that DNase-treated samples were
free from genomic contamination a reverse-transcriptase negative control (lacking
enzyme) was carried out for every RNA sample. Complementary DNA generated
from 50 ng (PXR, GR, TAT and CYP3A4) or 50 pg (18S rRNA) of total RNA was
ampliﬁed using TaqMan Universal polymerase chain reaction (PCR) Master Mix
with 400 nM primers and 200 nM ﬂuorogenic probe in a total reaction volume of
25ml. Quantitative PCR reactions were run on the ABI7000 SDS instrument and
quantiﬁed out using the ABI proprietary software against a standard curve gen-
erated from human genomic DNA (Promega).
Protein level measurement. Total protein extracts (10 mg per lane) were resolved
on 12% SDS-polyacrylamide gels and then transferred electrophoretically to
Hybond ECL nitrocellulose membranes (Amersham Biosciences, Little Chalfont,
Bucks, UK). Membranes were blocked (1 h) in 5% fat-free dried milk and then
probed with primary antibodies against human PXR (SAB2101636, 1:350; Sigma-
Aldrich) or a-actin (sc1616, 1:500; Autogen Bioclear), followed by anti-rabbit IgG
(sc2030, 1:10000; Autogen Bioclear) or anti-goat IgG (sc 2020, 1:20,000; Autogen
Bioclear), respectively. Bound antibodies were visualized using enhanced chemi-
luminescence reagents according to the manufactures instructions (Amersham
Biosciences).
CYP3A4 protein activity measurement. CYP3A4 enzyme activity was
determined using the P450-Glo activity system (Promega, Southampton, UK), as
per the manufacturer’s instructions. Brieﬂy, Luciferin-PPXE substrate was mixed
with S9 protein extract from primary human hepatocytes, along with an nicoti-
namide adenine dinucleotide phosphate regeneration system and detection reagent.
Following 20-min incubation, luminescence was quantiﬁed using a Packard
Lumicount.
In silico modelling. In silico models were generated using CellDesigner (v4.0.1;
Systems Biology Institute, http://celldesigner.org/index.html), a graphical front-end
for creating process diagrams of biochemical networks in systems Biology Markup
Language (ref. 28). Each individual chemical or protein is identiﬁed as a species
(s1.....sn), while interactions between species are identiﬁed as reactions (r1....rn).
For each reaction, a kinetic term can be included, detailing the mathematics
underlying the interaction between the species. For more complex analysis,
CellDesigner-generated models were transferred to COPASI (v4.6, build 32)
(ref. 40), which is another Systems Biology Markup Language-compliant
programme, but with a wider variety of analysis options.
A number of the parameter values used within the model were ﬁtted to the
known biological behaviour of the system, while maintaining these parameters
within previously determined biologically realistic bounds. To examine the
robustness of the conclusions drawn within this paper we undertook a sensitivity
analysis for these eight parameters. As detailed in Supplementary Tables S9 and
S10, our conclusions were mostly robust for up to a 10-fold change in any
individual parameter value. The only exception was the expression level of CYP3A4
within Fig. 3, as affected by the rate of GRL-dependent PXR transcription; Kd of
PXRL to CYP3A4 gene; and the rate of PXRL-dependent CYP3A4 transcription.
Given that sensitivity is only observed for Fig. 3, where a second ligand pool is
included, and not in Fig. 2, where the L2 pool is absent, it is logical to conclude that
the L2 pool is, at least in part, responsible for the observation. We conclude that the
increased basal expression of CYP3A4 due to the L2 pool may decrease the
robustness of the system to ﬂuctuations in these parameters. Importantly,
despite this altered behaviour, decreased levels of CYP3A4 are more pronounced
in the PXR stubborn variant, which is consistent with the central conclusions
of this paper.
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